Phibro Animal Health Q2 net income down 59% to $7.2M; guidance lowered on environmental costs

PHIBRO ANIMAL HEALTH CORP

2023-Q2 EPS reported $0.27 revenue$477,167,000

Net sales $244.6M (+5% YoY); GAAP diluted EPS $0.18 vs $0.43 prior; adjusted diluted EPS $0.34 vs $0.37.
Adjusted EBITDA $30.9M (+6% YoY); Animal Health segment grew 9% while Mineral Nutrition declined 8%.
Recorded $6.6M environmental remediation cost from tentative settlement of California contamination lawsuit.
Updated FY23 guidance: Net income lowered to $34-38M (from $39-43M); adjusted metrics unchanged.
Free cash flow -$45M over trailing 12 months due to inventory build to mitigate supply chain risk.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PHIBRO ANIMAL HEALTH CORP reported financial results for the fiscal quarter ended December 31, 2022.

Period: the fiscal quarter ended December 31, 2022
Result: reported results

Exact text from the filing

On February 8, 2023, Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR

accession 0001558370-23-001038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.